Deal facts
- Buyer
- EKF Diagnostics Holdings plc
- Target
- Beep Insights AB
- Deal value
- Not disclosed
- Announced
- 13 April 2026
- Status
- Firm intention
- Sector
- Healthcare
- Country
- Sweden
- Consideration
- cash
Sources
EKF Diagnostics Holdings plc has agreed to acquire Beep Insights AB, a Swedish company operating within the diagnostics sector. The transaction is structured as a strategic acquisition with consideration provided in cash. This deal was announced on 13 April 2026, marking a significant expansion for the buyer into the Nordic market. The target operates from Sweden and brings specific capabilities to the combined entity, though the specific financial value of the transaction remains undisclosed.
The agreement reflects a firm intention to proceed with the acquisition, pending the necessary regulatory approvals and other standard closing conditions. As the deal is currently in the pre-completion phase, the finalisation date has not yet been confirmed. This acquisition represents a key strategic move for EKF Diagnostics Holdings plc to strengthen its market position through the integration of Beep Insights AB. The parties are expected to complete the transaction once all regulatory hurdles are cleared.
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- Firm intention
EKF Diagnostics Holdings plc to acquire Beep Insights AB
{ "headline": "Acquisition of assets from Beep Insights", "issuer": "EKF Diagnostics Holdings (EKF)", "announcement_date": "2026-04-13T07:00:00", "category_code": "Class 2 Acquisition", "body": "Disclaimer* \n\n \n\n \n\n EKF Diagnostics Holdings plc \n\n (\"EKF\" or the \"Company\") \n\n \n\n Acquisition of technology assets from Beep Insights AB \n\n Real-time glucose and lactate t
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Shuttle Pharmaceuticals Holdings, Inc. to acquire United Dogecoin Inc.
Shuttle Pharmaceuticals Holdings, Inc. and United Dogecoin Inc. entered the Exit Mode archive.
- Buyer
- Shuttle Pharmaceuticals Holdings, Inc.
- Target
- United Dogecoin Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
MedPal AI plc to acquire Remedi Solutions Limited
MedPal AI plc and Remedi Solutions Limited entered the Exit Mode archive.
- Buyer
- MedPal AI plc
- Target
- Remedi Solutions Limited
- Deal value
- GBP 310,000
- Deal type
- strategic acquisition
BIOMARIN PHARMACEUTICAL INC to acquire Amicus
BIOMARIN PHARMACEUTICAL INC and Amicus entered the Exit Mode archive.
- Buyer
- BIOMARIN PHARMACEUTICAL INC
- Target
- Amicus
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Telomir Pharmaceuticals, Inc. to acquire TELI Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. and TELI Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Telomir Pharmaceuticals, Inc.
- Target
- TELI Pharmaceuticals, Inc.
- Deal value
- USD 34,389,710
- Deal type
- strategic acquisition
GSK plc to acquire 35Pharma Inc.
GSK plc has agreed to acquire 35Pharma Inc., a Canadian biopharmaceutical company, for an equity value of USD 950 million. The transaction was structured as a strategic…
- Buyer
- GSK plc
- Target
- 35Pharma Inc.
- Deal value
- USD 950,000,000
- Deal type
- strategic acquisition
Buyer history
EKF Diagnostics Holdings plc
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
